Add To...

    ABIO  Arca Biopharma Inc.

    Exchange

    NASDAQ

    Sector

    Health Care

    Industry

    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    Market Cap.

    8.1M

    Vuru Grade

    36.87/100

    Current Price

    $2.55
    -0.01 (-0.39%)

    Growth Price

    $-3.90
    Why is this negative?

    Stability Price

    $0.66
    Overvalued by 74.14%

    Company Overview

    Management
    Financial Strength
    Economic Moat
    Dividends & Buybacks

    Company Metrics

    • 0 P/E
    • 0 P/S
    • 2.46 P/B
    • -1.61 EPS
    • 27,049.10% Cash ROIC
    • 7.88 Cash Ratio
    • 0 / 0% Dividend
    • 167,387.00 Avg. Vol.
    • 10.04M Shares
    • 8.1M Market Cap.

    Company Description

    ARCA biopharma, Inc., a biopharmaceutical company, engages in the development of genetically-targeted therapies for cardiovascular diseases. Its principal product candidate, Gencaro (bucindolol hydrochloride), is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure and also for the prevention of atrial fibrillatio...
    more


    Download 10 Years of Financial Statements:
    Income Statement   Balance Sheet   Cash Flow

    News

    ARCA BIOPHARMA, INC. : arca Announces Death of Board Member Burton E ...
    4-traders (press release) - May 7, 2013
    Broomfield, CO, May 6, 2013 -ARCA biopharma, Inc. (Nasdaq: ABIO), today announced that Burton E. Sobel, 75, a member of its Board of Directors, has died.
    ARCA Announces Death of Board Member Burton E. Sobel, Preeminent ... - Business Wire (press release)
    NASDAQ Decliners Watch List: Catalyst Pharmaceutical Partners Inc. (NASDAQ ...
    SBWire (press release) - Apr 24, 2013
    ARCA biopharma, Inc. (NASDAQ:ABIO) a biopharmaceutical company that focuses on developing genetically-targeted therapies for cardiovascular diseases closed down in its previous session (-11.03%) on 406,414 shares traded after ARCA BIOPHARMA, ...
    Colorado stocks: Real Goods Solar up 50%; Dow off 19 points (Video)
    Denver Business Journal - May 21, 2013
    The other actively traded stocks with the biggest gains were Royal Gold Inc. (RGLD), up 6.16 percent, or $3.01, to $51.87; and Bill Barrett Corp.
    Arca partners with Medtronic in clinical trial
    Boulder County Business Report - Apr 30, 2013
    BROOMFIELD - Arca Biopharma Inc. will use a heart monitor made by Medtronic Inc. in a clinical trial for Arca's heart drug Gencaro.
    Cancer Diagnostic Testing World Markets
    MarketWatch (press release) - May 22, 2013
    Companies Entering the Cancer Diagnostics Market with Novel Technology Platforms 2006.1 Abbott Diagnostics 2006.2 Affymetrix, Inc. 2016.3 Agendia BV 2026.4 Ambrilia Biopharma, Inc. 2026.5 ArcticDx, Inc. 2036.6 Arcxis Biotechnologies 2036.7 Asuragen ...
    Powerful Quantity Losers : MCOX, OGEN, CPRX, ABIO
    SBWire (press release) - Apr 24, 2013
    ARCA biopharma, Inc. (NASDAQ:ABIO) a biopharmaceutical company that focuses on developing genetically-targeted therapies for cardiovascular diseases closed down in its previous session (-11.03%) on 406,414 shares traded after ARCA BIOPHARMA, ...
    Colorado stocks: Gasco Energy gains 10%; Dow up 106 points (Video)
    Denver Business Journal - Apr 30, 2013
    QEP Resources Inc. (QEP): up 3.28 percent, or 91 cents, to $28.68. Among declining stocks, Arca Biopharma Inc. (ABIO) had the biggest percentage decrease.
    Colorado stocks: General Moly climbs 11%; Dow up 24 points
    Denver Business Journal - Apr 26, 2013
    Crocs Inc. (CROX): up 3.22 percent, or 51 cents, to $16.34. • Kodiak Oil & Gas Corp. (KOG): up 2.74 percent, or 21 cents, to $7.87.
    Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund ...
    Seeking Alpha - May 5, 2013
    The biotech group as represented by the NYSE ARCA Biotech Index ($BTK) has been strong recently, up about 30% in the last twelve months, while the broader market indices are up about 13% during the same period.